Cytarabine/Daunorubicin (7+3)

cytarabine and daunorubicin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cytarabine/Daunorubicin (7+3), covering 2026-03-25 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Revumenib in Combination With 7+3 + Midostaurin in AML [Phase 1]